Picture of GC Cell logo

144510 GC Cell Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m-16.43%
3m-10.44%
6m+14.92%
1yr-13.18%
Volume Change (%)
10d/3m-63%
Price vs... (%)
52w High-26.33%
50d MA-11.84%
200d MA-4.19%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital0.71%
Return on Equity-0.03%
Operating Margin2.23%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m57,895.1185,562.37168,310236,120.07187,544.19193,300n/a29.94%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/a+627.23-37.5-98.06+3353.56n/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of GC Cell EPS forecast chart

Profile Summary

GC Cell Corp formerly Green Cross Lab Cell Corp is a Korea-based company principally engaged in the provision of specimen testing services. The Company operates its business through four segments. The Specimen Testing Service segment provides sample testing services, clinical trial services, and veterinary testing services. The Cell Therapy segment is engaged in cell culture and technology transfer business. The Cord Blood Storage segment is engaged in the cord blood storage business. The Other Business segment is engaged in bio-logistics business and others.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
June 21st, 2011
Public Since
June 23rd, 2016
No. of Shareholders
45,720
No. of Employees
427
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KOSDAQ
Shares in Issue
15,022,641

144510 Share Price Performance

Upcoming Events for 144510

Q1 2024 GC Cell Corp Earnings Release

Q2 2024 GC Cell Corp Earnings Release

Similar to 144510

Picture of DreamCIS logo

DreamCIS

kr flag iconKorea Exchange - KOSDAQ

Picture of DT&CRO Co logo

DT&CRO Co

kr flag iconKorea Exchange - KOSDAQ

Picture of IMBDX logo

IMBDX

kr flag iconKorea Exchange - KOSDAQ

Picture of Labgenomics Co logo

Labgenomics Co

kr flag iconKorea Exchange - KOSDAQ

Picture of SLS Bio Co logo

SLS Bio Co

kr flag iconKorea Exchange - KOSDAQ

FAQ